SCHEMBL8869447

SCHEMBL8869447

CCOCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCC(=O)OC)nc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.49
EGFR P00533 2/20 0.43
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CA2 P00918 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
POLB P06746 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868459 0.94 HPGD (0.48) P4HTMEGFRHPGDSMN1; SMN2NPC1
SCHEMBL8867993 0.94 P4HTM (0.46) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8869631 0.93 P4HTM (0.53) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8869667 0.92 P4HTM (0.53) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8869204 0.92 P4HTM (0.53) P4HTMEGFRHPGDSMN1; SMN2NPC1
SCHEMBL8868196 0.92 P4HTM (0.53) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8869141 0.92 P4HTM (0.45) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8868438 0.91 P4HTM (0.48) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8869146 0.91 P4HTM (0.44) P4HTMEGFRHPGDSMN1; SMN2CA2
SCHEMBL8868013 0.90 P4HTM (0.50) P4HTMEGFRHPGDSMN1; SMN2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed